Product Images Imatinib Mesylate

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 5 images provide visual information about the product associated with Imatinib Mesylate NDC 0904-6901 by Major Pharmaceuticals, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

chemical-structure - Imatinib Molecule

chemical-structure - Imatinib Molecule

figure-1 - figure 1

figure-1 - figure 1

figure-2 - figure 2

figure-2 - figure 2

The text provided is a table with some data points related to patients and their treatment with drugs called Imatinib Mesylate, IFN4ARAC. The table presents different numbers, including the number of patients with progression of AP or BC and those censored at discontinuation, as well as a ratio, a Log-rank Test, and the time frame in months. The meaning and context of this table are not clear, so no further details can be provided.*

carton label - image 01

carton label - image 01

This text is describing a medication called Imatinib Mesylate, which comes in tablet form. The tablet is 1 mg and is only available with a prescription. The label lists the National Drug Code (NDC) as 0904-6901-04 and provides information about the dosage, precautions, and storage of the medication. The tablet is produced by a company called Major and is distributed by Argv. There is also a lot number listed, but no other information is available.*

carton label - image 02

carton label - image 02

This is a description of a medication called Imatinib Mesylate, which comes in tablet form. The National Drug Code (NDC) for this medication is 0904-6621-04 and it is only available with a prescription. Each bottle contains 470 mg of the medication, which is equivalent to 530 mg of it according to the text. The dosage information should be obtained from the prescription and precautions must be taken while storing the medication. The medication must be kept away from children and should not be used without following the prescription. The packaging appears to be designed for use in a hospital or clinical setting. The manufacturer appears to be MAJOR RENACR TICALS.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.